Myxofibrosarcoma

general

A malignant fibroblastic neoplasm arising from the soft tissue. It is characterized by the presence of spindle-shaped cells, cellular pleomorphism, thin-walled blood vessels, fibrous septa, and myxoid stroma.

75

Centers

100

Active Trials

$16M

Cancer Funding

Specific Cancer Types(1)

NameCenters
Unresectable Myxofibrosarcoma11

Top Centers for Myxofibrosarcoma(75)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
84.0
2
NCI Comprehensive
High-Volume Research Center
71.8
3
High-Volume Research Center
71.8
4
High-Volume Research Center
71.8
5
NCI Comprehensive
Active Research Program
66.7
6
NCI Comprehensive
Active Research Program
66.7
7
NCI Comprehensive
Active Research Program
66.7
8
NCI Comprehensive
Active Research Program
66.7
9
NCI Comprehensive
Active Research Program
66.7
10
NCI Comprehensive
Active Research Program
66.7
11
NCI Clinical
Active Research Program
66.7
12
Active Research Program
66.7
13
Active Research Program
66.7
14
Active Research Program
66.7
15
Active Research Program
66.7
16
Active Research Program
66.7
17
Active Research Program
66.7
18
NCI Comprehensive
Active Research Program
47.2
19
NCI Comprehensive
Active Research Program
46.9
20
NCI Comprehensive
Active Research Program
46.9
21
NCI Comprehensive
Active Research Program
46.9
22
NCI Comprehensive
Active Research Program
46.9
23
NCI Comprehensive
Active Research Program
46.9
24
NCI Comprehensive
Active Research Program
46.9
25
NCI Comprehensive
Active Research Program
46.9
26
NCI Comprehensive
Active Research Program
46.9
27
NCI Comprehensive
Active Research Program
46.9
28
NCI Comprehensive
Active Research Program
46.9
29
NCI Comprehensive
Active Research Program
46.9
30
NCI Comprehensive
Active Research Program
46.9
31
NCI Comprehensive
Active Research Program
46.9
3246.9
33
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
46.9
34
NCI Comprehensive
Active Research Program
46.9
35
NCI Comprehensive
Active Research Program
46.9
36
NCI Comprehensive
Active Research Program
46.9
37
NCI Comprehensive
Active Research Program
46.9
38
NCI Comprehensive
Active Research Program
46.9
39
NCI Comprehensive
Active Research Program
46.9
40
NCI Clinical
Active Research Program
46.9
41
NCI Comprehensive
Active Research Program
46.9
42
NCI Comprehensive
Active Research Program
46.9
43
NCI Comprehensive
Active Research Program
46.9
44
NCI Comprehensive
Active Research Program
46.9
45
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
46.9
46
NCI Comprehensive
Active Research Program
46.9
47
Active Research Program
46.9
48
NCI Comprehensive
Active Research Program
46.9
49
NCI Comprehensive
Active Research Program
46.9
50
NCI Clinical
Active Research Program
46.9
51
NCI Comprehensive
Active Research Program
46.9
52
NCI Comprehensive
Active Research Program
46.9
53
NCI Comprehensive
Active Research Program
46.9
54
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
46.9
55
NCI Clinical
Active Research Program
46.9
56
NCI Comprehensive
Active Research Program
46.9
57
Active Research Program
46.9
58
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
46.9
59
NCI Comprehensive
Active Research Program
46.9
6046.9
61
Active Research Program
46.9
62
Active Research Program
46.9
63
Active Research Program
46.9
64
Active Research Program
46.9
65
Active Research Program
46.9
66
Active Research Program
46.9
6746.9
68
Active Research Program
46.9
69
Active Research Program
46.9
70
BC CancerVancouver, BC
Active Research Program
46.9
71
NCI Comprehensive
29.5
7229.5
73
NCI Comprehensive
29.5
74
NCI Basic_laboratory
29.5
7529.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →